Segundo Buján

1.6k total citations · 1 hit paper
12 papers, 945 citations indexed

About

Segundo Buján is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Segundo Buján has authored 12 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Rheumatology and 4 papers in Molecular Biology. Recurrent topics in Segundo Buján's work include Systemic Lupus Erythematosus Research (6 papers), Inflammasome and immune disorders (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Segundo Buján is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Inflammasome and immune disorders (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Segundo Buján collaborates with scholars based in Spain, United Kingdom and France. Segundo Buján's co-authors include Jordi Yagüe, Juan I. Aróstegui, Pablo Pelegrı́n, Ana Isabel Gómez Córdoba, Estíbaliz Ruiz‐Ortiz, Carlos Martínez, Jordi Antón, Alberto Baroja‐Mazo, Fatima Martín‐Sánchez and David Brough and has published in prestigious journals such as Nature Immunology, The American Journal of Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

Segundo Buján

10 papers receiving 929 citations

Hit Papers

The NLRP3 inflammasome is released as a particulate dange... 2014 2026 2018 2022 2014 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Segundo Buján Spain 9 558 419 193 92 91 12 945
Estíbaliz Ruiz‐Ortiz Spain 12 686 1.2× 424 1.0× 135 0.7× 141 1.5× 106 1.2× 32 1.1k
Leigh D Church United Kingdom 17 537 1.0× 484 1.2× 209 1.1× 88 1.0× 66 0.7× 24 1.1k
Vilma Urbonaviciute Germany 16 361 0.6× 941 2.2× 273 1.4× 51 0.6× 50 0.5× 29 1.3k
Kristīne Oļeiņika United Kingdom 8 292 0.5× 688 1.6× 69 0.4× 57 0.6× 44 0.5× 12 1.1k
Wen‐Chan Tsai Taiwan 20 248 0.4× 466 1.1× 514 2.7× 103 1.1× 58 0.6× 82 1.3k
Yuan Min Wang Australia 22 273 0.5× 685 1.6× 97 0.5× 192 2.1× 350 3.8× 45 1.3k
Jialin Teng China 21 367 0.7× 486 1.2× 481 2.5× 84 0.9× 74 0.8× 75 1.2k
Thomas Ernandez Switzerland 14 238 0.4× 230 0.5× 71 0.4× 99 1.1× 196 2.2× 36 845
William McCormack Ireland 11 238 0.4× 453 1.1× 59 0.3× 124 1.3× 36 0.4× 17 839
J. Herbert United Kingdom 6 280 0.5× 483 1.2× 146 0.8× 135 1.5× 33 0.4× 10 1.0k

Countries citing papers authored by Segundo Buján

Since Specialization
Citations

This map shows the geographic impact of Segundo Buján's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Segundo Buján with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Segundo Buján more than expected).

Fields of papers citing papers by Segundo Buján

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Segundo Buján. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Segundo Buján. The network helps show where Segundo Buján may publish in the future.

Co-authorship network of co-authors of Segundo Buján

This figure shows the co-authorship network connecting the top 25 collaborators of Segundo Buján. A scholar is included among the top collaborators of Segundo Buján based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Segundo Buján. Segundo Buján is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Castillo, Alfredo, et al.. (2024). Nailfold videocapillaroscopy abnormalities and vascular manifestations in Behçet's syndrome. Clinical and Experimental Rheumatology. 42(10). 2065–2070.
2.
Ionescu, Daniela, Anna Mensa‐Vilaró, Paola Castillo, et al.. (2021). First Description of Late‐Onset Autoinflammatory Disease Due to Somatic NLRC4 Mosaicism. Arthritis & Rheumatology. 74(4). 692–699. 17 indexed citations
3.
Pardos‐Gea, José, et al.. (2021). Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome: a 38-year follow-up study. Lara D. Veeken. 61(3). 1053–1061. 19 indexed citations
4.
Soláns-Laqué, Roser, J. Loureiro, Ana Marín, et al.. (2018). SAT0455 Clinical and immunological characteristics of patients with suspected sjÖgren syndrome and anti-ro52 positive antibodies. Annals of the Rheumatic Diseases. 77. 1086–1087. 1 indexed citations
5.
Vento‐Tormo, Roser, Damiana Álvarez‐Errico, Antonio García-Gómez, et al.. (2016). DNA demethylation of inflammasome-associated genes is enhanced in patients with cryopyrin-associated periodic syndromes. Journal of Allergy and Clinical Immunology. 139(1). 202–211.e6. 57 indexed citations
6.
Baroja‐Mazo, Alberto, Fatima Martín‐Sánchez, Ana Isabel Gómez Córdoba, et al.. (2014). The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nature Immunology. 15(8). 738–748. 640 indexed citations breakdown →
7.
Bosch, J., Esther Pallisa, Fernando Martínez‐Valle, et al.. (2014). AB0548 Interstitial Lung Disease (ILD) in Primary SjÖGren Syndrome: Clinical, Immunological and Radiological Features and Outcome. Annals of the Rheumatic Diseases. 73. 987–987.
8.
Cortés-Hernández, Josefina, Josep Ordi‐Ros, Moisés Labrador‐Horrillo, et al.. (2004). Antihistone and anti–double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. The American Journal of Medicine. 116(3). 165–173. 73 indexed citations
9.
Buján, Segundo, et al.. (2003). Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients. Annals of the Rheumatic Diseases. 62(9). 859–865. 46 indexed citations
10.
Balada, Eva, et al.. (2002). Atherosclerosis and anti-oxidized low density lipoprotein antibodies in an elderly population. Medicina Clínica. 119(5). 161–165. 9 indexed citations
11.
Ordi‐Ros, Josep, et al.. (2000). Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy.. PubMed. 27(6). 1429–33. 63 indexed citations
12.
Ja, Capdevila, Segundo Buján, Joan Gavaldà, Adelaida Ferrer, & Albert Pahissa. (1997). Rhodococcus equi Pneumonia in Patients Infected with the Human Immunodefficiency Virus. Report of 2 cases and review of the literature. Scandinavian Journal of Infectious Diseases. 29(6). 535–541. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026